>>> Europe : Brokers Upgrades & Downgrades - 10th of December 2024 V2(+)

>>> Up
* British Land Raised to Buy at Goldman; PT 500 pence
* DWS Raised to Overweight at JPMorgan; PT 48 euros
* Hershey PT Raised to $190 from $166 at TD Cowen
* Hikma Raised to Outperform at RBC
* Interpublic Raised to Equal-Weight at Wells Fargo; PT $34
* Norwegian Cruise Raised to Buy at Goldman; PT $35
* Qiagen Raised to Buy at Jefferies
* Swissquote Raised to Add at AlphaValue/Baader
* Telecom Italia Raised to Overweight at Barclays
* Unite Group Raised to Overweight at JPMorgan; PT 1,070 pence
* UPS Raised to Outperform at BMO; PT $150

>>> Down
* Allfunds Cut to Underperform at Oddo BHF; PT 4.60 euros
* BT Cut to Equal-Weight at Barclays; PT 190 pence
* Cofinimmo Cut to Underweight at JPMorgan; PT 63 euros
* CompuGroup Cut to Hold at Berenberg; PT 22 euros
* EDP SA Cut to Hold at HSBC; PT 3.80 euros
* EDP Renovaveis Cut to Hold at HSBC; PT 11.70 euros
* FCC Cut to Add at AlphaValue/Baader
* Gecina Cut to Neutral at JPMorgan; PT 110 euros
* Kojamo Cut to Underweight at JPMorgan; PT 10.50 euros
* Klepierre Cut to Underweight at JPMorgan; PT 30 euros
* KPN Cut to Equal-Weight at Barclays; PT 4.20 euros
* LondonMetric Cut to Neutral at JPMorgan; PT 226 pence
* Ninety One Cut to Underweight at JPMorgan; PT 159 pence
* Schroders Cut to Neutral at JPMorgan; PT 353 pence
* Snam Cut to Hold at HSBC; PT 4.90 euros

>>> Initiation
* AT&T Rated New Outperform at Bernstein; PT $28
* Cambi Rated New Buy at Pareto Securities; PT 19 kroner (+)
* Carbios SACA Rated New Buy at Stifel; PT 19 euros
* DSV Rated New Outperform at Wolfe; PT 1,900 kroner
* Embla Medical HF Rated New Buy at Intron Health; PT 56 kroner
* Jubilee Metals Group Reinstated Outperform at RBC; PT 8.30 pence
* Schneider Electric Rated New Equal-Weight a=t Oxcap
* SOL Rated New Buy at Equita; PT 46 euros (+)
* T-Mobile Rated New Market Perform at Bernstein; PT $265
* Truecaller Rated New Buy at Nordea; PT 62 kronor

>>> Call
* Buy Europe Stocks in 2025 as Pessimism Peaking: Citi’s Manthey
* Volatility to Again Impact European Financials in 2025: JPMorgan
* Embla Medical Has Multiple Upside Drivers, New Buy at Intron
* Hikma Upgraded at RBC, Offers Attractive, Diversified Growth
* JPMorgan Sees Opportunities in Property, Yields Remain Challenge